Study links GLP-1s with serious gastrointestinal conditions
Glucagon-like peptide-1 (GLP-1) agonists are associated with an increased risk of serious medical conditions including stomach paralysis,...
Study links GLP-1s with serious gastrointestinal conditions
T2DM diagnosis at age 30 can reduce life expectancy by up to 14 years
Worldwide audit finds testosterone replacement improves glycaemic control in men for up to two years
ASMBS appoints Diane Enos as new Executive Director
Rejuva GLP-1-based pancreatic gene therapy candidate results in greater weight loss vs. semaglutide
Journal Watch 4/10/2023
Researchers find target for prompting fat cells to expend energy